| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3976747 | Brachytherapy | 2016 | 6 Pages |
Abstract
Outcomes for favorable IR were superior to those with unfavorable IR. Within the confines of this study, neither the addition nor dose of supplemental EBRT influenced BF, PCSM, or OM in patients with IR disease.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Gregory S. Merrick, Kent E. Wallner, Robert W. Galbreath, Wayne M. Butler, Edward Adamovich,